Northern Trust Corp Aerie Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$6.37 - $15.23 $36,194 - $86,536	5,682 Added 1.26%	457,539 $6.92 Million
Q2 2022 Aug 12, 2022	BUY	$4.95 - $9.16 $49,504 - $91,609	10,001 Added 2.26%	451,857 $3.39 Million
Q1 2022 May 13, 2022	SELL	$5.64 - $9.8 $112,055 - $194,706	-19,868 Reduced 4.3%	441,856 $4.02 Million
Q4 2021 Feb 08, 2022	SELL	$7.02 - $13.33 $7,378 - $14,009	-1,051 Reduced 0.23%	461,724 $3.24 Million
Q3 2021 Nov 15, 2021	SELL	$11.32 - $16.63 $196,549 - $288,746	-17,363 Reduced 3.62%	462,775 $5.28 Million
Q2 2021 Aug 13, 2021	BUY	$15.16 - $18.97 $415,035 - $519,341	27,377 Added 6.05%	480,138 $7.69 Million
Q1 2021 May 12, 2021	SELL	$13.12 - $20.9 $366,507 - $583,841	-27,935 Reduced 5.81%	452,761 $8.09 Million
Q4 2020 Feb 11, 2021	SELL	$9.12 - $14.49 $118,505 - $188,283	-12,994 Reduced 2.63%	480,696 $6.49 Million
Q3 2020 Nov 16, 2020	SELL	$10.46 - $14.46 $210,978 - $291,658	-20,170 Reduced 3.93%	493,690 $5.81 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $255,480 - $343,407	-21,290 Reduced 3.98%	513,860 $7.59 Million
Q1 2020 May 14, 2020	BUY	$11.84 - $25.52 $62,302 - $134,286	5,262 Added 0.99%	535,150 $7.22 Million
Q4 2019 Feb 14, 2020	SELL	$17.72 - $25.1 $962,479 - $1.36 Million	-54,316 Reduced 9.3%	529,888 $12.8 Million
Q3 2019 Nov 13, 2019	BUY	$18.41 - $28.0 $2.31 Million - $3.51 Million	125,507 Added 27.36%	584,204 $11.2 Million
Q2 2019 Aug 13, 2019	SELL	$28.97 - $48.21 $1.11 Million - $1.84 Million	-38,165 Reduced 7.68%	458,697 $13.6 Million
Q1 2019 May 13, 2019	BUY	$36.32 - $49.25 $1.1 Million - $1.49 Million	30,215 Added 6.47%	496,862 $23.6 Million
Q4 2018 Feb 12, 2019	SELL	$33.0 - $60.04 $96,261 - $175,136	-2,917 Reduced 0.62%	466,647 $16.8 Million
Q3 2018 Nov 14, 2018	BUY	$56.15 - $73.9 $636,123 - $837,213	11,329 Added 2.47%	469,564 $28.9 Million
Q2 2018 Sep 18, 2018	SELL	$47.85 - $70.45 $123,548 - $181,901	-2,582 Reduced 0.56%	458,235 $31 Million
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $1.3 Million - $1.92 Million	27,269 Added 6.29%	460,817 $31.1 Million
Q1 2018 May 09, 2018	BUY	$51.15 - $61.0 $375,850 - $448,228	7,348 Added 1.72%	433,548 $23.5 Million
Q4 2017 Feb 14, 2018	BUY	$50.85 - $65.1 $8,339 - $10,676	164 Added 0.04%	426,200 $25.5 Million
Q3 2017 Nov 13, 2017	BUY	$48.6 - $60.1 $20.7 Million - $25.6 Million	426,036	426,036 $20.7 Million

Others Institutions Holding AERI

# of Institutions

Shares Held

2.4M

Call Options Held

Put Options Held

View Full List

About AERIE PHARMACEUTICALS INC

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

More about AERI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account